Future Insights: Russia’s Viscosupplementation Market Set to Achieve US$ 84.86 Million by 2032 with a 6.2% CAGR | FMI

The Russia Viscosupplementation Market is poised to surpass a valuation of US$ 84.86 million by 2032, exhibiting a robust 6.2% CAGR through 2032, as revealed by the latest report from Future Market Insights titled “Viscosupplementation Market: Russia Industry Analysis and Opportunity Assessment, 2016-2026.” In 2016, nearly 70% of viscosupplementation revenues in Russia were attributed to three-injection viscosupplementation, amounting to over RUB 1.13 billion (US$ 19 million) in revenue. With a consistent growth rate of 5.8% CAGR, Russia’s viscosupplementation market is projected to reach an impressive RUB 2.02 billion (US$ 34 million) by the conclusion of 2026.

With higher demand for three-injection viscosupplementation, Russia’s healthcare industry leaders will continue to extend production of three-injection viscosupplementation products as opposed to single-injection and five-injection viscosupplementation products.

Click Here to Request a sample copy of this Report
https://www.futuremarketinsights.com/reports/sample/rep-ru-2897

Russia’s healthcare infrastructure will continue witnessing a significant rise in a number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. The rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation as an ideal medical procedure for injecting lubricating fluid in bone joints during surgeries. An in-depth analysis of Russia’s viscosupplementation market, conducted by Future Market Insights, projects that demand for three-injection viscosupplementation will gain traction over the next decade.

The report also establishes projections regarding the end-use of viscosupplementation in Russia. Hospitals across the country will account for just above RUB 1.24 billion (US$ 21 million) revenues by the end of projection period. Within this, the demand for viscosupplementation will remain considerably higher in hospitals with capacity of more than 500 beds. End-use of viscosupplementation in Russia’s ambulatory surgical centres (ASCs) will remain nascent, while revenues accounted by orthopaedic clinics are expected to surpass RUB 595 million (US$ 10 million) through 2026.

Top Players in Russia’s Viscosupplementation Market

Top three established players in Russia’s Viscosupplementation market include Hyaltech, Croma-Pharma GmbH and TRB Chemedica. The market is fragmented with small players holding substantial market share. While Hyaltech, Croma-Pharma GmbH and TRB Chemedica collectively dominate with more than half of the country’s viscosupplementation revenues.

Discovering the assumptions behind the study. Ask an Analyst
https://www.futuremarketinsights.com/ask-question/rep-ru-2897

International players such as Sanofi, Ferring Pharmaceuticals and Fidia Farmaceutici spa have low share as compared to the other players, Anika Therapeutics has recently launched their viscosupplementation product in Russia’s viscosupplementation market.

The market is divided into two segments based on product type and end use:

By Product Type

• Single Injection Viscosupplementation
• Three Injection Viscosupplementation
• Five Injection Viscosupplementation

By End Use

• Hospitals
  • 500+ Bedded
  • 250-500 Bedded
  • Less Than 250 Bedded
•  Ambulatory Surgical Centres
• Orthopaedic Clinics

Get Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-ru-2897

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube